NSN 6505-01-411-2724
Part Details | LORAZEPAM INJECTION
6505-01-411-2724
Alternate Parts: 950128, 95-0128, NDC00641604825, NDC00641-6048-25, NDC00641604425, NDC00641-6044-25, NDC00641600125, NDC00641-6001-25, 6505-01-411-2724, 01-411-2724, 6505014112724, 014112724
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAR 21, 1995 | 01-411-2724 | 50832 ( LORAZEPAM INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-411-2724
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 95-0128 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC00641-6048-25 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
| NDC00641-6044-25 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
| NDC00641-6001-25 | 32655 | WEST-WARD PHARMACEUTICALS CORP. |
Technical Data | NSN 6505-01-411-2724
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER CONTENT QUANTITY | 1.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY2.000 MILLIGRAMS LORAZEPAM |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LORAZEPAM INJECTION 2MG/ML 1ML VIAL 25S PG |
| CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
